publication date: Dec. 19, 2010
In this issue:
Combined analysis moves Herceptin to adjuvant setting in breast cancer.
Breast cancer session was ASCO equivalent of a rock concert, discussant says.
Avastin doubles progression-free survival in metastatic disease.
Also MQSA should require mammography facilities to gather data on interpretation, cancer policy board committee says.
Colorado universities install huge NMR magnet. NCI to transfer 5 A Day to CDC.
Download (PDF 502KB)
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.